Middle East Pharmaceutical Industries Co.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Middle East Pharmaceutical Industries Co."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 16.88% vs 16.43% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.55% vs 21.28% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "460.50",
          "val2": "394.00",
          "chgp": "16.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "128.40",
          "val2": "105.70",
          "chgp": "21.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.30",
          "val2": "3.70",
          "chgp": "-10.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "97.00",
          "val2": "79.80",
          "chgp": "21.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "235.40%",
          "val2": "228.10%",
          "chgp": "0.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

460.50

394.00

16.88%

Operating Profit (PBDIT) excl Other Income

128.40

105.70

21.48%

Interest

3.30

3.70

-10.81%

Exceptional Items

0.00

0.00

Consolidate Net Profit

97.00

79.80

21.55%

Operating Profit Margin (Excl OI)

235.40%

228.10%

0.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 16.88% vs 16.43% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 21.55% vs 21.28% in Dec 2024

All Annual Results